ReviewJournal of clinical medicine2026
Sodium-Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps-A Structured Narrative Review.
Maria Rada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.